Luoxin Pharmaceuticals Group Stock Co., Ltd. (SHE:002793)
China flag China · Delayed Price · Currency is CNY
4.310
+0.140 (3.36%)
Jul 3, 2026, 3:04 PM CST

SHE:002793 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
4,6885,0954,0555,8298,34215,181
Market Cap Growth
-7.62%25.65%-30.44%-30.12%-45.05%-0.22%
Enterprise Value
5,1846,0555,3056,87611,05616,161
Last Close Price
4.314.803.825.367.6710.34
PE Ratio
-----37.38
PS Ratio
1.972.241.532.472.332.34
PB Ratio
3.994.122.782.272.523.21
P/TBV Ratio
6.586.664.542.933.003.76
P/FCF Ratio
22.5923.07-25.97--
P/OCF Ratio
19.6820.14-12.49-125.85
EV/Sales Ratio
2.182.662.002.913.082.50
EV/EBITDA Ratio
99.01163.70---22.90
EV/EBIT Ratio
-----31.10
EV/FCF Ratio
24.9827.41-30.63--
Debt / Equity Ratio
1.040.891.120.591.100.60
Debt / EBITDA Ratio
23.4424.12---3.97
Debt / FCF Ratio
5.914.97-6.77--
Net Debt / Equity Ratio
0.360.440.810.320.660.17
Net Debt / EBITDA Ratio
9.6014.70-4.16-2.86-1.561.17
Net Debt / FCF Ratio
2.032.46-4.333.68-1.91-4.37
Asset Turnover
0.620.560.560.360.410.75
Inventory Turnover
2.853.023.512.353.864.77
Quick Ratio
0.560.510.480.790.851.34
Current Ratio
0.760.840.701.081.081.59
Return on Equity (ROE)
-19.47%-21.11%-52.20%-26.16%-31.26%9.28%
Return on Assets (ROA)
-2.49%-2.46%-6.31%-4.53%-11.35%3.77%
Return on Invested Capital (ROIC)
-9.03%-7.17%-15.79%-10.81%-28.99%8.96%
Return on Capital Employed (ROCE)
-12.10%-11.10%-26.50%-15.00%-42.70%9.50%
Earnings Yield
-5.76%-5.66%-23.81%-11.34%-14.68%2.67%
FCF Yield
4.43%4.33%-6.74%3.85%-13.59%-1.24%
Dividend Yield
-----0.29%
Payout Ratio
-----32.59%
Buyback Yield / Dilution
-3.44%0.39%1.65%23.91%1.79%0.51%
Total Shareholder Return
-3.44%0.39%1.65%23.91%1.79%0.80%